SecBot SecBot

ACOG

Alpha Cognition Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. A1· CIK 0001655923 Biotech & Drug Discovery
$8.34 +0.03 (+0.36%)
Oct 23 4:00 PM ET · prev $8.31
Market cap
$180.9M
Micro cap
Consensus
Buy
91% Buy or better · 11 analysts
Median target
🔒 Subscribers only
1 year
+21.4%
from $6.87 · Oct 24
30 days
−2.7%
from $8.57
52-week range
$4.50–9.75
−14% from high · low Feb 5
Avg volume 20D
100.7K
shares / day
Short interest
323.4K
≈1.5% of shares · +54.6%
Days to cover
2.8
at average volume
Insider net
+$6.7M
3 buyers · 0 sellers · since Mar 3
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 2 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/4
Strongest BULLISH Opaleye Management Inc., a 10% owner of Alpha Cognition, purchased a total of 31,700 shares on the open…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    3 insiders bought $6.7M at an average $7.11. No open-market sales. Price is 17% above their cost.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 1 trimmed or exited.

  • AnalystsBULLISH

    10 of 11 rate it Buy or better.

  • Short sellersBUILDING

    Short interest +54.6% to 323.4K shares. 2.8 days to cover, ≈1.5% of shares.

  • TrendDOWNTREND

    7% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED1,456$10.5K
JONES FINANCIAL COMPANIES LLLPDOUBLED250$1.6K
ROYAL BANK OF CANADANEAR_EXIT122$1.0K
UBS Group AGTRIM438$2.4K
TWO SIGMA INVESTMENTS, LPDOUBLED57,572$374.2K
MARSHALL WACE, LLPTRIM53,203$345.8K
UBS Group AGDOUBLED927$6.0K
NATIONAL BANK OF CANADA /FI/TRIM5,292$34.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 91% rate it Buy or better
Strong Buy2Buy8Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Aug 20, 2026B. Riley Securities
INITIATE
INITIATEBuy
Aug 17, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Jul 10, 2026Raymond James
INITIATE
INITIATEOutperform
May 29, 2026Maxim Group
INITIATE
INITIATEBuy
May 22, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy

Insider ledger

Form 4
$6.7M
bought · 3 insiders
$0
sold · 0 insiders
+17.4%
vs their $7.11 cost
DateInsiderTypeValue
Oct 16, 2026
Opaleye Management Inc.
10%+ Owner
BUY$117.6K
Oct 15, 2026
Opaleye Management Inc.
10%+ Owner
BUY$191.0K
Oct 1, 2026
Opaleye Management Inc.
10%+ Owner
BUY$165.6K
Sep 25, 2026
Opaleye Management Inc.
10%+ Owner
BUY$113.7K
Sep 24, 2026
Opaleye Management Inc.
10%+ Owner
BUY$157.1K
Sep 16, 2026
Opaleye Management Inc.
10%+ Owner
BUY$454.6K
Sep 16, 2026
Opaleye Management Inc.
10%+ Owner
BUY$228.0K
Sep 15, 2026
Opaleye Management Inc.
10%+ Owner
BUY$28.8K

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
323,405
shares short
+54.6%
vs prior settlement
2.8
days to cover
≈1.5%
of shares outstanding
Trading halts
Aug 3, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 Insider
Opaleye Management Inc. bought 14,283 shares
10%+ Owner @ $8.23 ($117.6K)
Oct 15, 2026 Insider
Opaleye Management Inc. bought 22,657 shares
10%+ Owner @ $8.43 ($191.0K)
Oct 1, 2026 Insider
Opaleye Management Inc. bought 19,050 shares
10%+ Owner @ $8.69 ($165.6K)
Sep 28, 2026 SEC
Opaleye Management Inc., a 10% owner of Alpha Cognition, purchased a total of 31,700 shares on the open market over…
INSIDER-BUY — Impact 5/10
Sep 23, 2026 SEC
Manchester Management Company, LLC and related entities filed a Schedule 13G disclosing a 6.9% passive stake in Alpha…
SC 13G — Impact 3/10
Sep 16, 2026 SEC
Opaleye Management Inc., a 10% owner of Alpha Cognition, purchased 43.8K shares for $380K in open-market transactions…
INSIDER-BUY — Impact 4/10
Aug 13, 2026 Earnings calendar
ACOG Q2 2026 Earnings Scheduled — 2026-08-13
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
1,456 shares ($10.5K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 13, 2026
Earnings date
ACOG Q2 2026 Earnings Scheduled — 2026-08-13
Aug 3, 2026
Trading halt
Halt Resumed: ACOG — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-08-03T14:00:33.000Z | Resumed 2026-08-03T14:05:33.000Z
Aug 3, 2026
Trading halt
Trading Halt: ACOG — LUDP (Volatility Trading Pause)
Alpha Cognition Inc. CS | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
May 14, 2026
Earnings date
ACOG Q1 2026 Earnings Scheduled — 2026-05-14
Mar 26, 2026
Earnings date
ACOG Q4 2025 Earnings Scheduled — 2026-03-26

SecBot reports

7 filings · 4 bullish · 0 bearish · 3 neutral
All ACOG filing & press-release reports (7)